Navigation Links
Novocure™ to Present NovoTTF™ Therapy Data at the 2012 Annual Scientific Meeting of the American Society of Clinical Oncology
Date:5/29/2012

ved marketing approval in the US and is a CE Marked device that is cleared for sale in Europe.

Approved Indication

The US Food and Drug Administration (FDA) has approved the NovoTTF™-100A System for use as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM), following histologically – or radiologically-confirmed recurrence in the supra-tentorial region of the brain after receiving chemotherapy.  The device is intended to be used as monotherapy, and is intended as an alternative to standard medical therapy for GBM after surgical and radiation options have been exhausted.

Patients should only use the NovoTTF-100A System under the supervision of a physician properly trained in use of the device. Full prescribing information is available at www.novottftherapy.com  or by calling toll free 1-855-281-9301.

Other Indications

Caution:  Investigational Device: Limited by U.S. law to investigational use for the treatment of newly diagnosed GBM, lung cancer and pancreatic cancer.  The safety and effectiveness of the NovoTTF-100A and NovoTTF-100L for these indications has not been established.

About Novocure

Novocure Limited is a private oncology company dedicated to pioneering the discovery and development of a novel therapy for solid tumors called NovoTTF™ that provides physicians and patients with a simple, predictable and empowering approach to treating solid tumors.  Novocure's worldwide headquarters is located in the Jersey Isle.  Novocure's U.S. operations are based in Portsmouth, NH and the company's research center is located in Haifa, Israel.  For additional information about the company, please visit www.novocure.com

Media contacts:

Frank Leonard

SOURCE Novocure
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)...  Rigrodsky & Long, P.A.: , Do you, ... LCI )? , Did you purchase your shares before ... 2014, inclusive? , Did you lose money in your ... to discuss your rights? Rigrodsky & ... Timothy J. MacFall , announces that a complaint has been filed ...
(Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com announces ... available in its catalogue: Needle-Free ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... technological and commercial prospects What does the ... Visiongain,s brand new report shows you the ...
(Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com announces that ... its catalogue: North America Laparoscopes Market ... North America Laparoscopes Market Outlook ... "North America Laparoscopes Market Outlook to 2020", provides ... market. The report provides value, in millions of ...
Breaking Medicine Technology:Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18North America Laparoscopes Market Outlook to 2020 2North America Laparoscopes Market Outlook to 2020 3North America Laparoscopes Market Outlook to 2020 4North America Laparoscopes Market Outlook to 2020 5North America Laparoscopes Market Outlook to 2020 6North America Laparoscopes Market Outlook to 2020 7North America Laparoscopes Market Outlook to 2020 8North America Laparoscopes Market Outlook to 2020 9North America Laparoscopes Market Outlook to 2020 10North America Laparoscopes Market Outlook to 2020 11
... 4 Reportlinker.com announces that a new ... catalogue: Stakeholder Opinions: Vaccines ... in Brazil, Mexico and Argentina ... IntroductionOver the past decade, vaccines have resurfaced ...
... Nov. 4, 2010 CardioGenics Holdings Inc. (OTC Bulletin Board: ... a private placement under which it has raised $1,930,575. The ... have registration rights and are, therefore, subject to the rights ... in connection with the private placement. The funding ...
Cached Medicine Technology:Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 2Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 3Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 4Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 5Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 6Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 7Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 8CardioGenics Raises $1.9 Million in Private Placement 2
(Date:8/29/2014)... 2014 PreDiabetes Centers , the country’s ... by offering Web shoppers a 20% discount off orders of ... Company’s online healthy living shop, beginning September 1. , ... when heading into the chilly fall season. , Autumn’s cooler, ... season, people usually ditch the healthy salads and opt for ...
(Date:8/29/2014)... "I have had many hospital stays, including five back ... surgeries in my lifetime, as I am a burn patient," ... was unable to move freely in order to prevent pneumonia, ... to physically rotate me every 30 minutes to 2 hours. ... the sheets. This was jarring and caused me major pain. ...
(Date:8/29/2014)... Los Angeles, CA (PRWEB) August 29, 2014 ... between good and bad fat. Brown fat is usually stored ... neck, while white fat typically reveals itself in overflowing bellies, ... While good fats occur naturally in many foods and promote ... negative health risks, including elevated bad cholesterol levels and lower ...
(Date:8/29/2014)... Princeview Dental ( http://www.princeviewdental.com ), one ... opinion on the most effective oral care for children ... and routines that are necessary for proper oral care ... Janice Mummery, Founder of Princeview Dental. “Not too much ... is still important, as is using the proper teeth ...
(Date:8/29/2014)... Beach, VA (PRWEB) August 29, 2014 ... the top ten tools for online teaching, as well ... for Best Course or Learning Management System, announced that ... Matt Contento, participated in the ALS Ice Bucket Challenge ... and challenge Paul Sanders, Edvance360 Co-Founder. , “We know ...
Breaking Medicine News(10 mins):Health News:PreDiabetes Centers Online Store Launches Fall Savings Event 2Health News:InventHelp® Client Develops Equipment for Surgical and Bedridden Patients (HCD-279) 2Health News:Diet Doc Announces Modernized, Interesting and Easy to Follow Diet Plans that Deliver Fast Weight Loss and Teach Patients the Difference Between Good and Bad Fat 2Health News:Diet Doc Announces Modernized, Interesting and Easy to Follow Diet Plans that Deliver Fast Weight Loss and Teach Patients the Difference Between Good and Bad Fat 3Health News:Princeview Dental, One of Etobicoke’s Trusted Dental Clinics, Announces the Best Tooth Brushing Practices for Kids 2Health News:Edvance360 Participates In the ALS Ice Bucket Challenge (#ALSicebucketchallenge) 2
... ... In celebration of National Registered Dietitian Day on March 10, the ... daily newsletter and website combining the best diet and nutrition information ... on Dietitians ( www.theskinnyondietitians.com ) online directory. Spearheaded by celebrity ...
... ... operating roles, investment banking and business development to LeveragePoint,s Board of Directors. ... Cambridge, MA (PRWEB) ... B2B Customer Value Management software for marketing and sales, today announced that entrepreneurial advisor ...
... ... ... ... ...
... Calif., March 10, 2010 A clinical research trial of ... has passed an important safety stage, according to the UC ... Cramer said patients showed no ill effects after the sequential ... stroke-damaged areas of the brain. All new drug treatments must ...
... Physicians may be able to safely lower ... bone-marrow transplant patients without risking increased bleeding, according ... and 28 other medical institutions. Reducing platelet ... administer transfusions could help address frequent shortages in ...
... ... ... ... ...
Cached Medicine News:Health News:New Interactive Dietitian Directory Launches on National Registered Dietitian Day: TheSkinnyonDietitians.com 2Health News:New Interactive Dietitian Directory Launches on National Registered Dietitian Day: TheSkinnyonDietitians.com 3Health News:New Interactive Dietitian Directory Launches on National Registered Dietitian Day: TheSkinnyonDietitians.com 4Health News:Peyton Marshall Joins LeveragePoint Innovations Board 2Health News:Peyton Marshall Joins LeveragePoint Innovations Board 3Health News:Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference 2Health News:Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference 3Health News:Fewer platelets could be used for some cancer and bone-marrow transplantation patients 2Health News:Update: MedQuist Wins Contract with Detroit Medical Center for Emergency Medicine Transcription at Six Healthcare Organizations 2Health News:Update: MedQuist Wins Contract with Detroit Medical Center for Emergency Medicine Transcription at Six Healthcare Organizations 3Health News:Update: MedQuist Wins Contract with Detroit Medical Center for Emergency Medicine Transcription at Six Healthcare Organizations 4
... quantitative microplate enzyme immunoassay that detects elevated levels ... small amounts of NMP22 protein in the urine. ... elevated in the urine of patients with bladder ... The use of the NMP22 protein has been ...
... cystometry and urethral pressure profilometry. The ... bladder to be filled while cystometry ... the catheter in the bladder for ... is standing or sitting. Supplied sterile ...
... for cystometry and urethral pressure profilometry. ... faster filling of the bladder and ... lumen catheter construction allows the bladder ... performed. Triple lumen catheter construction allows ...
... Compact desktop analyzer for fast point-of-care ... syndrome, deep vein thrombosis and/or pulmonary embolism. ... rooms. , ,When every minute counts, ... determination of troponin T, myoglobin, and D-Dimer ...
Medicine Products: